drugset / Trial / NCT04460443
Sofosbuvir in Treatment of COVID 19
RandomizedParallel-groupOpen-labelTreatment
Summary
Sofosbuvir containing treatment in treatment of COVID 19 Egyptian patients
Timeline
- Start
- 2020-08-01
- Primary completion
- 2021-08-01
- Completion
- 2021-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daclatasvir | Small molecule | — | — |
| Subject | Sofosbuvir | Small molecule | — | — |
| Subject | ledipsavir | Unknown | — | — |